期刊文献+

癌抗原125、癌抗原199及骨桥蛋白联合检测对卵巢上皮癌的诊断价值 被引量:1

Value of Combined Detection of Cancer Antigen 125,Cancer Antigen 199 and Osteopontin in Diagnosis of Epithelial Ovarian Cancer
下载PDF
导出
摘要 目的探讨癌抗原125、癌抗原199及骨桥蛋白联合检测对卵巢上皮癌(EOC)的诊断价值。方法选择2010年6月至2012年5月在苏州市立医院住院治疗的EOC患者(EOC组)40例、卵巢上皮良性肿瘤患者(BEOT组)40例及门诊体检的健康女性(对照组)40例。检测EOC组、BEOT组治疗前后和对照组血清癌抗原125、癌抗原199及骨桥蛋白水平。评价血清癌抗原125、癌抗原199和骨桥蛋白单独检测及三者联合检测的方法学指标对EOC的诊断价值。结果 EOC组治疗后与治疗前各指标比较差异有统计学意义(P<0.05);治疗后血清癌抗原125、癌抗原199及骨桥蛋白水平EOC组明显高于对照组、BEOT组,EOCⅢ期、EOCⅣ期均明显高于EOCⅠ期、EOCⅡ期(均P<0.05),而对照组与BEOT组比较差异无统计学意义(P>0.05);血清癌抗原125、癌抗原199及骨桥蛋白三者联合检测的敏感性较单独检测大幅提高(P<0.05);骨桥蛋白+癌抗原125联合检测可提高对浆液性EOC的检出率(85.0%),骨桥蛋白+癌抗原199联合检测可提高对黏液性EOC的检出率(87.5%),三者联合检测对黏液性EOC及浆液性EOC的检出率均高于单独检测及2种方法联合检测(均P<0.05)。结论血清癌抗原125、癌抗原199及骨桥蛋白三者联合检测对EOC具有较高的诊断价值。 Objective To investigate the value of combined detection of cancer antigen 125,cancer antigen 199 and osteopontin in the diagnosis of epithelial ovarian cancer(EOC).MethodsForty patients with EOC(EOC group)and 40 patients with benign epithelial ovarian tumors(BEOT group)who were treated in Suzhou Municipal Hospital between June 2010 and May 2012 were selected in this study.In addition,40 healthy subjects were selected as control group.Serum levels of cancer antigen 125,cancer antigen 199 and osteopontin were measured before and after treatment,and diagnostic values of the three indicators and their combination were evaluated.Results There were significant differences in the three indicators before and after treatment in EOC group(P〈0.05).Compared with control or BEOT group,serum levels of cancer antigen 125,cancer antigen 199 and osteopontin significantly increased in EOC group after treatment(P〈0.05).Compared with stageⅠ orⅡ EOC,serum levels of cancer antigen 125,cancer antigen 199 and osteopontin significantly increased in stage Ⅲ and Ⅳ EOC(P〈0.05).No significant differences in the levels of the three indicators between control group and BEOT group(P〉0.05).Compared with separate detection,the sensitivity was significantly increased by combined detection of the three indicators(P〈0.05).The detection rate of serous EOC was increased to 85.0%by combined osteopontin and cancer antigen 125 measurement,and the detection rate of mucinous EOC was increased to 87.5% by combined osteopontin and cancer antigen 199 measurement.Compared with separate measurement or combined measurement of two indicators,the detection rates of serous and mucinous EOC were significantly improved by combined measurement of three indicators(P〈0.05).Conclusion Combined detection of cancer antigen 125,cancer antigen 199 and osteopontin in serum has higher value in the diagnosis of EOC.
作者 张勤英 朱凡
出处 《南昌大学学报(医学版)》 CAS 2014年第11期44-47,共4页 Journal of Nanchang University:Medical Sciences
关键词 卵巢上皮癌 卵巢上皮良性肿瘤 癌抗原125 癌抗原199 骨桥蛋白 肿瘤标记 生物学 epithelial ovarian cancer benign epithelial ovarian tumors cancer antigen 125 cancer antigen 199 osteopontin tumor markers biology
  • 相关文献

参考文献13

二级参考文献55

  • 1周碧芳,裴红,吴强,周宝琴.40岁以下妇女卵巢上皮性癌73例临床分析[J].江苏医药,2006,32(12):1156-1157. 被引量:1
  • 2关珊,李永辉,宋鸿碧,陈琨,杨英捷.上皮性卵巢癌生存率及预后因素分析[J].贵阳医学院学报,2007,32(2):177-178. 被引量:7
  • 3Whitehouse C, Solomon Eo Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening [J]. Gynecol Oncol, 2003, 88(1Pt 2): S152-S157.
  • 4Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomised controlled trial[J]. Lancet, 1999,353(9160) : 1207 -1210.
  • 5van den Heuvel-Eibrink MM, Sonneveld P, Pieters R. The prognostic significance of membrane transport-associated mul tidrug resistance (MDR) proteins in leukemia[J]. Int J Clin Pharmacol Ther, 2000,38 (3) : 94-110.
  • 6Takano M, Kudo K, Goto T, et al. Analyses by comparative genomic hybridization of genes relating with cisplatin-resistance in ovarian cancer[J].Hum Cell, 2001,14(4) : 267-271.
  • 7Varadi A, Szakacs G, Bakos E, et al. P glycoprotein and the mechanism of multidrug resistance[J]. Novartis Found Syrup, 2002, 243(1):54-65.
  • 8Ozalp SS, Yalcin OT, Tanir M, et al. Multidrug resistance gene-1 (Pgp) expression in epithelial ovarian malignancies[J]. Eur J Gynaecol Oneol, 2002,23(4) : 337-340.
  • 9徐昊平,金冶宁.食管癌肿瘤细胞放疗后加速再增殖及相关治疗[J].现代肿瘤医学,2007,15(8):1194-1196. 被引量:5
  • 10Wang K,Gan L,Jeffrey E,et al.Monitoring genes expression profile changes in ovarian carcinomas using cDNA microarray[J].Gene,1999,299(1/2):101-108.

共引文献39

同被引文献11

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部